Biotest AG BIOTEST ORD SHS/ DE0005227201 /
| 15/11/2024 13:17:19 | Chg. -1.00 | Volume | Bid06:00:04 | Ask06:00:04 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 41.00EUR | -2.38% | - Turnover: - |
-Bid Size: - | -Ask Size: - | 2.41 bill.EUR | - | 12.69 |
Assets
| 2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 414.9000 | 477.1000 | 512.7000 | 521.9000 | 522.2000 | ||||||
| Intangible Assets | 25.3000 | 16.6000 | 16.4000 | 13.8000 | 14 | ||||||
| Long-Term Investments | 8 | 13 | 7.4000 | 7.6000 | .2000 | ||||||
| Fixed Assets | 465.6000 | 528.8000 | 547.2000 | 585.6000 | 575 | ||||||
| Inventories | 170.8000 | 146.9000 | 208.3000 | 280.1000 | 290.1000 | ||||||
| Accounts Receivable | 163.8000 | 133.8000 | 118.7000 | 107.7000 | 115.8000 | ||||||
| Cash and Cash Equivalents | 72.9000 | 22.3000 | 61.9000 | 60.8000 | 71.3000 | ||||||
| Current Assets | 467.2000 | 449.7000 | 495.1000 | 522.8000 | 556.3000 | ||||||
| Total Assets | 932.8000 | 978.5000 | 1,042.3000 | 1,108.4000 | 1,131.3000 | ||||||
Liabilities
| 2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 62.8000 | 65 | 73.4000 | 52.2000 | 42 | ||||||
| Long-term debt | 330 | 286.8000 | 328.7000 | 402.9000 | 462.5000 | ||||||
| Liabilities to Banks | 346.2000 | 406.4000 | 329.4000 | 410.4000 | 470.4000 | ||||||
| Provisions | 49.5000 | 30.6000 | 29.3000 | 28.9000 | 29.4000 | ||||||
| Liabilities | 572.1000 | 630.7000 | 547.1000 | 631.5000 | 689.7000 | ||||||
| Share Capital | 39.6000 | 39.6000 | 39.6000 | 39.6000 | 39.6000 | ||||||
| Total Equity | 360.5000 | 347.6000 | 495 | 476.9000 | 441.6000 | ||||||
| Minority Interests | .2000 | .2000 | .2000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 932.8000 | 978.5000 | 1,042.3000 | 1,108.4000 | 1,131.3000 | ||||||
Income Statement
| 2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 553.1000 | 378.1000 | 400.3000 | 419.1000 | 484.2000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 63.9000 | -9.3000 | 10.6000 | -1.2000 | -1.3000 | ||||||
| Interest Income | -12.6000 | -16.8000 | -11.3000 | -10.5000 | -28.2000 | ||||||
| Income Before Taxes | 52.7000 | -26 | -6 | -1.3000 | -30 | ||||||
| Income Taxes | 18.2000 | -9.6000 | 6.9000 | 3.4000 | 1.4000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -45.7000 | -3.5000 | 181.7000 | -4.7000 | -31.4000 | ||||||
Per Share
Cash Flow
| 2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 65.9000 | 34.3000 | -50 | -33.6000 | -16.7000 | ||||||
| Cash Flow from Investing Activities | -34 | -148 | 200.8000 | -8 | -14.6000 | ||||||
| Cash Flow from Financing | -1.7000 | 55.2000 | -111.2000 | 40.5000 | 42 | ||||||
| Decrease / Increase in Cash | 30.2000 | -58.5000 | 39.6000 | -1.1000 | 10.7000 | ||||||
| Employees | 2,732 | 2,683 | 1,663 | 1,837 | 1,928 | ||||||
